anagrelide

FDA Drug Profile — anagrelide

anagrelide is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including anagrelide. Available dosage form: capsule.

Drug details

Generic Name
anagrelide
Brand Names
anagrelide
Application Number
ANDA209151
Sponsor
Torrent Pharmaceuticals Limited
NDC Codes
4
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
ANAGRELIDE HYDROCHLORIDE ANHYDROUS

Indications and Usage

1 INDICATIONS AND USAGE Anagrelide is a platelet reducing agent indicated for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. ( 1 ) Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events .

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.